References
- Bataille, L., Rahier, J., Geubel, A. (2002). Delayed and prolonged cholestatic hepatitis with ductopenia after long-term ciprofloxacin therapy for Crohn’s disease. J Hepatol 37: 696–699.
- Boerema, J., Boll, B., Muytjens, H., Branolte, J. (1985). Efficacy and safety of ciprofloxacin in the treatment of patients with complicated urinary tract infections. J Antimicrob Chemother 16:211–217.
- Brown, E. M., Morris, R., Stephenson, T. P. (1986). The efficacy and safety of ciprofloxacin in the treatment of chronic Pseudomonas aeruginosa urinary tract infection. J Antimicrob Chemother 18(Suppl D):123–127.
- Fass, R. J. (1987). Efficacy and safety of oral ciprofloxacin for treatment of serious urinary tract infections. Antimicrob Agents Chemother 31:148–150.
- Goetz, M., Galle, P. R., Schwarting, A. (2003). Non-fatal acute liver injury possibly related to high-dose ciprofloxacin. Eur J Clin Microbiol İnfect Dis 22:294–296.
- Grassmick, B. K., Lehr, V. T., Sundareson, A. S. (1992). Fulminant hepatic failure possibly related to ciprofloxacin. Ann Pharmacother 26:636–639.
- Labowitz, J. K., Silverman, W. B. (1997). Cholestatic jaundice induced by ciprofloxacin. Dig Dis Sci 42:192–194.
- Villenueve, J. P. Davies, C., Cote, J. (1995). Suspected ciprofloxacin-induced hepatotoxicity. Ann Pharmacother 29:257–259.
- Zaidi, S. (2003). Hepatitis associated with amoxicillin/clavulanic acid and/or ciprofloxacin. Am J Med Sci 325:31–33.
- Zimpfer, A., Propst, A., Mikuz, G., Vogel, W., Terracciano, L., Stadlmann, S. (2004). Ciprofloxacin-induced acute liver injury: case report and review of literature [review]. Virch Arch 444: 87–89.